Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:58 PM
Ignite Modification Date:
2025-12-24 @ 7:58 PM
NCT ID:
NCT06566404
Eligibility Criteria:
Inclusion Criteria:
* male or female, aged at least 18 years;
* histologically documented melanoma;
* thickness \> 2 mm (\>pT3b);
* clinical node-negative (cN0) and non-metastatic (cM0) disease at ultrasound (US) and computed tomography (CT) or positron emission tomography (PET) scan;
* known BRAF, N-ras proto-oncogene (NRAS) and tyrosine-protein kinase (c-KIT) mutational status;
* candidate to SLNB;
* consent for the provision of plasma samples for ctDNA analysis and tissue samples (at a central laboratory).
Exclusion Criteria:
* SLNB performed;
* receipt of neoadjuvant therapy.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
99 Years
Study:
NCT06566404
Study Brief:
Protocol Section:
NCT06566404